Journal of the American Society of Nephrology · 1995 · 353 citations · 17 references
DialysisDialysis TherapyRenal FunctionPublic HealthChronic Kidney DiseaseHemodialysisRenal CareHealth PolicyPeritoneal DialysisKidney FailureOutcomes ResearchModality ChoiceEnd-stage Renal DiseaseEpidemiologyTreatment AssignmentUrologyRenal DiseaseDeath RatesKidney TransplantationMedicineNephrologyEmergency Medicine
Patients with ESRD treated with dialysis have a high mortality rate. Controversy exists as to whether this high mortality rate is affected by modality choice. The purpose of this epidemiologic study was to compare mortality in prevalent hemodialysis-treated (HD) and peritoneal dialysis-treated (PD) patients in a large national sample, adjusting for demographic characteristics. Data were obtained from the U.S. Renal Data System for patients prevalent on January 1 of the years 1987, 1988, and 1989, each with 1 yr of follow-up. Patients were censored at transplantation. Death rates per 100 patient years were compared between HD and PD, adjusting for age, race, gender, cause of ESRD (diabetes versus nondiabetes) and < 1 yr or > 1 yr of prior ESRD, by the use of Poisson regression. There were 42,372 deaths occurring over 170,700 patient years at risk. On average, prevalent patients treated with PD had a 19% higher adjusted mortality risk (relative risk (RR) = 1.19; P < 0.001) than did those treated with HD. This risk was found to be insignificant (P > 0.05) and small for ages < 55 and increasingly large and significant for ages > 55 yr. It was accentuated in diabetics (RR = 1.38; P < 0.001) but was also present in nondiabetics (RR = 1.11; P < 0.001). Although present in both males and females, this risk was accentuated in females (RR = 1.30 versus 1.11; both P < 0.001). In this national study of prevalent U.S. dialysis patients, treatment assignment to PD was associated with a 19% higher all-cause mortality rate than HD.(ABSTRACT TRUNCATED AT 250 WORDS)
17
The influence of dialysis treatment modality on the decline of remaining renal function.
Michael J. Lysaght, Edward F. Vonesh, Frank A. Gotch et al. · PubMed · 1992 · 298 citations